NITI Aayog released the 8th edition of the 'Trade Watch Quarterly (TWQ)' for Q4 (January-March 2026) of FY2025-26 in New Delhi, in the presence of Nidhi Chhibber, interim CEO of NITI Aayog. This edition focuses on the pharmaceutical sector with special emphasis on Active Pharmaceutical Ingredients (APIs). The global pharmaceutical market recorded an estimated demand of USD 1.3 trillion in 2025. India's pharmaceutical sector contributes over 1.7% to GDP and accounts for 7.2% of manufacturing GVA.
Economy
NITI Aayog Releases 8th Edition of Trade Watch Quarterly, Focusing on Pharmaceutical Sector and APIs
Key Points
- NITI Aayog released the 8th edition of the 'Trade Watch Quarterly (TWQ)' for Q4 (January-March 2026) of FY2025-26 in New Delhi, in the presence of Nidhi Chhibber, interim CEO of NITI Aayog
- This edition focuses on the pharmaceutical sector with special emphasis on Active Pharmaceutical Ingredients (APIs)
- The global pharmaceutical market recorded an estimated demand of USD 1.3 trillion in 2025
- India's pharmaceutical sector contributes over 1.7% to GDP and accounts for 7.2% of manufacturing GVA
📋
📎 Read original source ↗Exam Note
• NITI Aayog Trade Watch Quarterly: 8th edition; Q4 FY26; pharma + API focus (June 2026) • Released in presence of Nidhi Chhibber (NITI Aayog interim CEO) • Global pharma market 2025: ~USD 1.3 trillion; India pharma GDP contribution: 1.7%+ • India pharma manufacturing GVA contribution: 7.2%; India known as 'World's Pharmacy'
